Rwandan health authorities have taken swift action following safety concerns surrounding antifungal tablets produced in Kenya.
The Rwanda Food and Drugs Authority (RFDA) issued a recall notice for all batches of 200 mg Fluconazole tablets manufactured by the Kenyan company Universal Corporation.
The directive, aimed at importers, mandates the return of these tablets due to discolouration issues discovered by the RFDA.
Specifically, four bulk batches of pink Fluconazole 200mg tablets showed white discolouration shortly after their shelf life began once imported into Rwanda.
Highlighting the urgency of the situation, the RFDA emphasized that some of these discoloured tablets had already entered the Rwandan market.
Consequently, retailers and health facilities have been instructed to cease distribution and return the affected drugs immediately.
As a precautionary measure, health officials in Rwanda have launched an investigation to ascertain whether these potentially compromised drugs have caused any adverse effects among consumers.
Amid these developments, Kenyan authorities are yet to announce whether the same antifungal drug, commonly used to treat fungal or yeast infections, will also undergo a recall within the local market.
Read: Ned Nwoke: Nigerians Should Be Allowed to Carry Guns
About The Author
Related Articles
Malian Army Says Dozens of Militants Killed in Airstrikes in Segou Region
Mali’s armed forces say they have killed about twenty suspected militants during...
Nigeria Approves 33 New Universities While Education Quality and Jobs Remain in Crisis
Nigeria has approved 33 new universities, bringing the total number of sanctioned...
Gabon Suspends Social Media “Until Further Notice” Amid Rising Unrest
Gabon’s media regulator has announced the suspension of social media platforms nationwide,...
Côte d’Ivoire Feeds the World’s Chocolate Industry, But When Prices Shift, Cocoa Farmers Are Left With Rotting Harvests and No Income
Côte d’Ivoire produces nearly half of the world’s cocoa, a crop that...